483
Davryan Laboratories, Inc.FDA 483 - Davryan Laboratories, Inc. - December 17, 2019
Discuss this record with AI
Record Details
An FDA inspection of Davryan Laboratories, Inc., a manufacturer of personal lubricants in Portland, OR, identified one observation. The firm was cited for not adequately establishing procedures for corrective and preventive action (CAPA). Specifically, documentation for verification of effectiveness for past CAPAs was not provided.
Open in Dashboard
ID · 4761a91e-875f-424c-a437-a0c40a01457c